A5014569727- Breast Cancer Treatment Studies
- Cancer Treatment and Pharmacology
- Hip disorders and treatments
- HER2/EGFR in Cancer Research
- Pharmacology and Obesity Treatment
- Dialysis and Renal Disease Management
- Appendicitis Diagnosis and Management
- Gallbladder and Bile Duct Disorders
- Ovarian cancer diagnosis and treatment
- Estrogen and related hormone effects
- Orthopaedic implants and arthroplasty
- Acute Kidney Injury Research
- BRCA gene mutations in cancer
- Mechanical Circulatory Support Devices
- Pharmaceutical studies and practices
- Fungal Infections and Studies
- Diabetes Treatment and Management
- Cancer Genomics and Diagnostics
- Pancreatitis Pathology and Treatment
- Cardiac Valve Diseases and Treatments
- Antifungal resistance and susceptibility
- Nail Diseases and Treatments
- PARP inhibition in cancer therapy
- Child and Adolescent Health
- Lung Cancer Research Studies
Hospital Universitario de Getafe
2024-2025
Hospital Universitario Virgen del Rocío
2018-2024
Instituto de Biomedicina de Sevilla
2024
Universidad de Sevilla
2024
Hospital Universitario de Guadalajara
2021
Hospital General Universitario Gregorio Marañón
2017
Congenital cutaneous candidiasis is an infrequent invasive fungal infection that usually appears in the first days of life. Extremely low birth weight infants are most frequently affected. Classic presentation includes diffuse extensive erythematous rash with papules, plaques, pustules and vesicles, which later undergoes desquamation. Systemic dissemination common extremely infants. Blood, urine cerebrospinal fluid evaluation should be included initial assessment. Early prolonged treatment...
The objective of this study was to analyze hematologic disorders, coagulation and transfusion requirements in children with continuous renal replacement therapies (CRRT). This is a retrospective analysis prospectively collected database receiving CRRT between 2010 2015. Patient characteristics, parameters, need for transfusions were recorded analyzed. We compared patients after heart surgery noncardiac patients, those requiring extracorporeal membrane oxygenation (ECMO) without ECMO,...
Abstract Background: Overexpression of HER2 is a significant prognostic and predictive factor in early breast cancer. positive tumors are those scored by immunohistochemistry (IHC) 3+ or 2+ with amplification situ hybridization (ISH). These may benefit from HER2-targeted treatment additionally, HER2-positive BC, achieving complete pathological response after neoadjuvant improves patient survival. In recent years, new anti-HER2 antibody-drug conjugates have proven effective for low BC...
e12651 Background: Achieving a pathological complete response (pCR) following neoadjuvant treatment (NAT) in HER2-positive tumors significantly enhances patient survival, resulting remarkable 92% reduction mortality risk. However, it is crucial to identify biomarkers capable of predicting the NAT response, moving towards more personalized medicine. This approach would enable identification patients likely respond specific therapies, thereby facilitating implementation targeted strategies....
e12608 Background: Achieving a pCR (absence of residual invasive disease in breast and measurable any the axillary nodes sampled, ypT0/is ypN0) after NAT correlates with improved survival. TNBC phenotype have poor prognosis. However, it is associated higher response rates. With traditional schemes based on anthracyclines taxanes, rates around 25-40% are obtained. Different been studied providing an increase such as using nab-paclitaxel, platinum salts, bevacizumab or dose dense (dd)...